Akebia Therapeutics (AKBA) Return on Assets (2014 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Return on Assets of 0.0% for Q1 2026, little changed year-over-year from 0.0% in Q1 2025, and down 284.59% quarter-over-quarter from 0.0% in Q4 2025.
Akebia Therapeutics (AKBA) Return on Assets (2014 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Return on Assets for 13 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Assets retreated to 0.0% in Q1 2026 per AKBA's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q4 2025 and bottomed at 0.01% in Q1 2022.
- Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
- On a YoY basis, Return on Assets climbed as much as 0 bps in 2022 and fell as far as 0 bps in 2022.
- Akebia Therapeutics' Return on Assets stood at 0.0% in 2022, then grew by 0 bps to 0.0% in 2023, then slumped by 49 bps to 0.0% in 2024, then jumped by 96 bps to 0.0% in 2025, then slumped by 285 bps to 0.0% in 2026.
- Business Quant data shows AKBA's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 0.00% |
| 10 | Akebia Therapeutics | 248.20 Mn | 92.65 Mn | 38.70 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |